Weight management

Mounjaro has been an “overwhelmingly positive experience” for PharmaDoctor’s chief executive Graham Thoms, but he stresses it’s neither a “magic bullet” nor a “short-term fix” and that uniform regulation must be implemented.

Patients using weight loss drugs in the UK have overwhelmingly opted for Mounjaro over Wegovy in the last six months, PharmaDoctor data has revealed.

Ex-social-media-influencer Georgie Aldous, who was able to take weight loss jab Mounjaro despite suffering with an eating disorder, has warned followers that the drug is “not worth the risk”.

An online pharmacy has come under fire for “treating injectable medications like grocery items at a Lidl checkout”.

The “first” NHS Mounjaro patients of a possible 3.4 million are set to receive the weight loss jab by March 2025, NICE has revealed in new draft guidance, while the first generic GLP-1 weight loss drug could soon follow.

A third of people believe that the NHS “should not” offer weight loss injections “to people who are obese”, an Ipsos survey has revealed.

The medicines regulator has ordered an online pharmacy to amend its advertising for medication “not licensed for weight loss” following a complaint, it has revealed.

A mum of three was landed in hospital shortly after taking weight loss jab Mounjaro, having “bought into” an online pharmacy’s ad for the drug on social media, C+D has learned.

Tesco has announced the launch of a new “dedicated health zone” to expand its pharmacy services such as weight management and provide customers with “easy and convenient” healthcare while they shop.

The medicines watchdog has received reports of some 10 deaths “with glucagon-like peptide-1 receptor agonists (GLP-1RAs) indicated for weight management” such as Wegovy and Mounjaro, C+D can reveal.